This content is in French.
Low-dose aspirin in hepatic steatosis
22 mars 2024
Aspirin has been shown to have an effect on the progression of hepatic steatosis to end-stage liver disease and hepatocellular carcinoma. But what is its effect on hepatic steatosis? In this randomized, double-blind…
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Tracey G Simon et al. Aspirin for Metabolic Dysfunction-Associated Steatotic Liver Disease Without Cirrhosis: A Randomized Clinical Trial. JAMA. 2024 Mar 19;331(11):920-929.
View the sourceOther recent articles
Psychological Therapies for Adults With ADHD: Meaningful Benefits, but Persistent Gaps in Outcomes
14 octobre 2026
Beyond Recovery: How Exercise-Based Cardiac Rehabilitation Improves Outcomes in Coronary Heart Disease
14 octobre 2026
Bowel Endometriosis: From Gastrointestinal Symptoms to Diagnosis and Management
9 octobre 2026